ES553961A0 - Un metodo para purificar la proteina inhibidora de fosfolipasa humana (hpip) - Google Patents

Un metodo para purificar la proteina inhibidora de fosfolipasa humana (hpip)

Info

Publication number
ES553961A0
ES553961A0 ES553961A ES553961A ES553961A0 ES 553961 A0 ES553961 A0 ES 553961A0 ES 553961 A ES553961 A ES 553961A ES 553961 A ES553961 A ES 553961A ES 553961 A0 ES553961 A0 ES 553961A0
Authority
ES
Spain
Prior art keywords
hpip
inhibiting protein
purify human
human phospholipase
phospholipase inhibiting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES553961A
Other languages
English (en)
Other versions
ES8800691A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biotechnology Research Partners Ltd
Original Assignee
Biotechnology Research Partners Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotechnology Research Partners Ltd filed Critical Biotechnology Research Partners Ltd
Publication of ES8800691A1 publication Critical patent/ES8800691A1/es
Publication of ES553961A0 publication Critical patent/ES553961A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4721—Lipocortins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/71—Expression systems using regulatory sequences derived from the trp-operon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • Rheumatology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
ES553961A 1985-04-15 1986-04-14 Un metodo para purificar la proteina inhibidora de fosfolipasa humana (hpip) Expired ES8800691A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US72304685A 1985-04-15 1985-04-15

Publications (2)

Publication Number Publication Date
ES8800691A1 ES8800691A1 (es) 1987-11-16
ES553961A0 true ES553961A0 (es) 1987-11-16

Family

ID=24904592

Family Applications (1)

Application Number Title Priority Date Filing Date
ES553961A Expired ES8800691A1 (es) 1985-04-15 1986-04-14 Un metodo para purificar la proteina inhibidora de fosfolipasa humana (hpip)

Country Status (6)

Country Link
EP (1) EP0218696A4 (es)
JP (2) JP2757987B2 (es)
AU (1) AU5770786A (es)
CA (1) CA1290267C (es)
ES (1) ES8800691A1 (es)
WO (1) WO1986006100A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879224A (en) * 1985-01-10 1989-11-07 Biogen, Inc. DNA sequences, recombinant DNA molecules and processes for producing human phospholipase inhibitor polypeptides
US4874743A (en) * 1985-01-10 1989-10-17 Biogen, Inc. DNA sequences, recombinant DNA molecules and processes for producing human phospholipase inhibitor-like polypeptides
AU601676B2 (en) * 1985-01-10 1990-09-20 Biogen, Inc. Dna sequences recombinant dna molecules and processes for producing human lipocorton-like polypeptides
US5081019A (en) * 1985-01-10 1992-01-14 Biogen, Inc. DNA sequences, recombinant DNA molecules and processes for producing lipocortin-like polypeptides
US4950646A (en) * 1985-01-10 1990-08-21 Biogen, Inc. DNA sequences, recombinant DNA molecules and processes for producing human lipocortin-like polypeptides
JPS6256429A (ja) * 1985-09-04 1987-03-12 Teijin Ltd フオスフオリパ−ゼａ↓２阻害活性を有する蛋白
PT87083B (pt) * 1987-03-28 1992-07-31 Boehringer Ingelheim Int Processo para a preparacao de uma proteina anticoagulante vascular, de adn que codifica para esta proteina e de composicoes farmaceuticas que a contem
JPH06799B2 (ja) * 1987-04-02 1994-01-05 帝人株式会社 起炎性フオスフオリパ−ゼａ▲下２▼阻害活性を有する蛋白
DE68923107T2 (de) * 1988-02-26 1996-01-18 Biogen Inc DNA-Sequenzen, rekombinante DNA-Moleküle und Verfahren zur Herstellung von Lipocortin III, IV, V, und VI.
US5519120A (en) * 1989-04-07 1996-05-21 Cancerforskningsfondet Af 1989 Urokinase-type plasminogen activator receptor antibodies
DE69033653T2 (de) * 1989-04-07 2001-06-07 Cancerforskningsfonden Af 1989 (Fonden Til Fremme Af Eksperimental Cancerforskning), Kopenhagen Plasminogen-aktivator-rezeptor vom urokinasetyp
US5891664A (en) * 1989-04-07 1999-04-06 Cancerforskningsfondet Af 1989 Vectors and methods for recombinant production of uPA-binding fragments of the human urokinase-type plasminogen receptor (uPAR)
US5344764A (en) * 1989-08-03 1994-09-06 Teijin Limited Protein inhibitors of phospholipase A2 purified from inflammatory sites and production process
WO1991001999A1 (fr) * 1989-08-03 1991-02-21 Teijin Limited Proteine d'inhibition de la phospholipase a2 naissant dans une region inflammee, sa production et gene prevu a cet effet
WO1991003544A1 (en) * 1989-08-29 1991-03-21 The Regents Of The University Of California Novel hydrolytic enzyme inhibitors and substrates and assays, methods and kits embodying same
DE69432608T2 (de) 1993-06-01 2004-02-26 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville Expression von inhibitoren vom plasminogenaktivator vom urokinasetyp
US6248715B1 (en) 1993-06-01 2001-06-19 Chiron Corporation Method of treating a urokinase-type plasminogen activator-mediated disorder
AU7036398A (en) * 1997-03-20 1998-10-20 Fondazione Centro San Raffaele Del Monte Tabor Upar mimicking peptide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU601676B2 (en) * 1985-01-10 1990-09-20 Biogen, Inc. Dna sequences recombinant dna molecules and processes for producing human lipocorton-like polypeptides
JPS6256429A (ja) * 1985-09-04 1987-03-12 Teijin Ltd フオスフオリパ−ゼａ↓２阻害活性を有する蛋白

Also Published As

Publication number Publication date
ES8800691A1 (es) 1987-11-16
JPS63500561A (ja) 1988-03-03
JP2637709B2 (ja) 1997-08-06
JP2757987B2 (ja) 1998-05-25
EP0218696A4 (en) 1989-08-16
CA1290267C (en) 1991-10-08
JPH08187087A (ja) 1996-07-23
EP0218696A1 (en) 1987-04-22
AU5770786A (en) 1986-11-05
WO1986006100A1 (en) 1986-10-23

Similar Documents

Publication Publication Date Title
ES553961A0 (es) Un metodo para purificar la proteina inhibidora de fosfolipasa humana (hpip)
ES557795A0 (es) Procedimiento para la purificacion de proteina amilaide a desuero (saa)
ES551225A0 (es) Procedimiento para la obtencion de poliesterpoliuretanos
FR2588747B1 (fr) Fixateur de valvule artificielle
ES551748A0 (es) Procedimiento para la obtencion de eteraminas terciarias
ES557547A0 (es) Procedimiento para la obtencion de 5-amino-1-piridil-pirazoles
ES557386A0 (es) Un ensayo inmunometrio para proteina p21ras humana
ES557549A0 (es) Procedimiento para la obtencion de quinoloncarboxilatos
ES552950A0 (es) Procedimiento para la obtencion de i-benzoil-3-aril-ureas
ES553569A0 (es) Procedimiento para la obtencion de carbamoilimidazoles
BR8607202A (pt) Bomba de lacadas
FR2591774B1 (fr) Systeme de fichier
ES555818A0 (es) Procedimiento para la obtencion de 5-amino-4-ciano-1-piridil-pirazoles
ES556306A0 (es) Procedimiento para preparar laminina humana
FR2561157B1 (fr) Systeme de rasoir
ES554820A0 (es) Procedimiento para la obtencion de benzotiazolsulfenamidas
ES554397A0 (es) Procedimiento para la formacion de calzado
ES553448A0 (es) Procedimiento para la obtencion de nuevas benzoilureas
ES554092A0 (es) Procedimiento para la obtencion de viniciclopropancarboxilatos
ES555029A0 (es) Procedimiento para la obtencion de 2-tiocromenilidenacetoacetatos
ES548295A0 (es) Procedimiento para la obtencion de la eritrosina sodica
ES549158A0 (es) Procedimiento para la obtencion de imidazo-benzodiazepinas sustituidas
ES550146A0 (es) Procedimiento para la obtencion de escualano
BR6501028U (pt) Encaixe de pulseira para relogio de pulso
FR2637197B1 (fr) Systeme et procede de distillation